Prophylaxis and treatment of osteoporosis based on bone density, loss of bone density and bone structures

The distinction between osteoporosis types 1 and 2 now serves mainly to emp hasize that type 1 is primarily trabecular and type 2 both trabecular and c ortical. In most cases (75%), fast bone loss is found in elderly patients w ith severe osteoporosis; only 34% of our fast bone losers were in early pos tmenopause. Our data support the use of antiresorptive substances, e.g. the vitamin D hormone metabolite, calcitriol, to treat fast bone losers with s evere osteoporosis. Anabolic agents, e.g. fluorides, are indicated in slow bone losers with their trabecular bone structures still relatively intact.